DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20184884

Effectiveness of CBNAAT in the diagnosis of extrapulmonary tuberculosis

Shivprasad Kasat, Mahendra Biradar, Ashish Deshmukh, Sunil Jadhav, Hafiz Deshmukh

Abstract


Background: Tuberculosis is still a major health problem worldwide. It is estimated that about one-third of the world's population is infected with mycobacterium tuberculosis. Whilepulmonary tuberculosis is most common presentation; extrapulmonary tuberculosis is also an important clinical problem. CBNAAT is cartridge based nucleic acid amplification test with a well-established role in the diagnosis of pulmonary tuberculosis (PTB). We determined the effectiveness of CBNAAT in the diagnosis of extrapulmonary tuberculosis (EPTB) cases in comparison to AFB smear.

Methods: Retrospective study of suspected extrapulmonary tuberculosis patients in a tertiary care centre of the study area was conducted. The study period was from January 2017 to July 2018. Data of 166 consecutive suspected extrapulmonary tuberculosis patients was retrieved. Effectiveness of CBNAAT in the diagnosis of EPTB was assessed as compared to that of AFB smear.

Results: Samples collected from 166 suspected EPTB patients were subjected to AFB smear and CBNAAT. Samples collected included lymph node, pus, pleural fluid, tissue, CSF, gastric lavage, cystic fluid, peritoneal fluid, ascitic fluid, colonic fluid, synovial fluid, urine. In AFB smear results, 17 cases were positive for TB bacilli and 149 were negative for the same. In CBNAAT results, 25 cases were positive for TB bacilli and 141 cases were negative. In comparative analysis, 8 cases were AFB smear negative but CBNAAT positive.

Conclusions: CBNAAT is a useful tool in the diagnosis of EPTB cases because of its simplicity and rapid turnaround time. CBNAAT is more effective as compared to AFB smear in the diagnosis of EPTB cases.


Keywords


CBNAAT, Extrapulmonary tuberculosis, Pleural effusion, Tuberculosis

Full Text:

PDF

References


World Health Organization. Global tuberculosis report 2012. Geneva, WHO, 2012. Available at: http://www.who.int/tb/publications/global_report/gtbr12_main.pdf.

Fundamental of tuberculosis. Global tuberculosis institute. Available at: globaltb.njms.rutgers.edu/downloads/products/Mantoux.../FundamentalsofTB.ppt. Accessed on 12 December 2017.

World Health Organization. Tuberculosis Fact Sheet. Fact Sheet No. 104. Available at: http://www.who.int/mediacenter/factsheets/fs104/en/print.html. Accessed on 15 February 2009.

Steinbrook R. Tuberculosis and HIV in India. New Engl J Med. 2007;356:1198-9.

Park K. Park’s Textbook of Preventive and Social Medicine. 24th ed. Jabalpur: M/s Banarsidas Bhanot Publishers;2017.

World Health Organization. Tuberculosis programme: Framework for effective tuberculosis control. Geneva, Switzerland: WHO;1994:179.

Sharma SK, Mohan A. Extrapulmonary tuberculosis. Ind J Med Res. 2004;120(4):31653.

Gupta S, Shenoy VP, Bairy I, Srinivasa H, Mukhopadhyay C. Diabetes mellitus and HIV as co-morbidities in tuberculosis patients of rural south India. J Infec Pub Heal. 2011 Aug 1;4(3):140-4.

Maurya AK, Kant S, Nag VL, Kushwaha RA, Dhole TN. Trends of anti-tuberculosis drug resistance pattern in new cases and previously treated cases of extrapulmonary tuberculosis cases in referral hospitals in northern India. J Postgrad Med. 2012;58(3):185-9.

Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K, et al. Rapid detection of Mycobacterium tuberculosis and rifampicin resistance by use of on-demand, near-patient technology. J Clin Microbiol. 2010 Jan;48(1):229-37.

Chaudhary A, Barve K, Desai U, Joshi J. Utility of GeneXpert in diagnosis of multidrug-resistant extrapulmonary tuberculosis. Inter J Recent Surg Med Sci. 2017;3(2):85-7.

Denkinger CM, Schumacher SG, Boehme CC, Dendukuri N, Pai M, Steingart KR. Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2014;44(2):435-46.

Penz E, Boffa J, Roberts DJ, Fisher D, Cooper R, Ronksley PE, James MT. Diagnostic accuracy of the Xpert MTB/RIF assay for extra-pulmonary tuberculosis: a meta-analysis. Int J Tuber Lung Dis. 2015 Mar;19(3):278-84.

Sharma SK, Kohli M, Chaubey J, Yadav RN, Sharma R, Singh BK, et al. Evaluation of Xpert MTB/RIF assay performance in diagnosing extrapulmonary tuberculosis among adults in a tertiary care centre in India. Eur Respir J. 2014 Oct;44(4):1090-3.